Porownywarka
Bivalirudin vs Oxytocin side-by-side
Zestaw do czterech peptydów według statusu dowodów, mechanizmów, dawkowania z badań, skutków ubocznych i referencji.
Porownywarka
Zestaw do czterech peptydów według statusu dowodów, mechanizmów, dawkowania z badań, skutków ubocznych i referencji.
Wybrane (2/4)
Udostępnij porównanie peptydów
| Wlasciwosc | Bivalirudin | Oxytocin |
|---|---|---|
| Kategoria | Inne | Hormonalne |
| Znany tez jako | Angiomax, Angiox | Pitocin, Syntocinon, The Love Hormone |
| Zatwierdzony przez FDA | Tak | Tak |
| Status kliniczny | FDA Approved - PCI anticoagulation
| FDA approved for labor and postpartum use; other uses remain under research
|
| Czego oczekiwac | Cardiac procedures, anticoagulation | Social bonding, anxiety, trust, emotional wellbeing |
| Jak dziala | Bivalirudin is described as a direct thrombin inhibitor derived from hirudin-related peptide design. It binds thrombin at two functional regions, including the active catalytic site and exosite 1, and the source notes activity against clot-associated thrombin as well as circulating thrombin. Its anticoagulant effect is characterized as reversible and relatively short lived because thrombin can gradually cleave the molecule. | Oxytocin acts through the oxytocin receptor, a G-protein-coupled receptor described in the source as present in the uterus, breast tissue, and multiple brain areas including the amygdala. In peripheral tissues, signaling is linked to calcium-mediated uterine contraction and milk ejection. Central effects are described as modulation of fear, reward, and social-attention circuitry, but intranasal research is difficult to interpret because the amount reaching the brain is uncertain and may involve indirect pathways. |
| Typowe dawkowanie | Limited community data available · See research protocols | 10-24 IU intranasal as needed · As needed · Intranasal |
| Dawkowanie z badań | 0.75 mg/kg IV bolus · Duration of procedure · IV bolus and infusion | 10-40 IU IV for labor · Single dose or short-term use · IV (obstetric); intranasal (research) |
| Typowy czas trwania | Duration of procedure | Single dose or short-term use |
| Podanie | IV bolus and infusion | IV in obstetric labeling; intranasal in research contexts |
| Timing | As directed by procedural protocol With or without food | As needed in studied social or bonding contexts With or without food |
| Poziom dowodów | Zatwierdzone przez FDA | Zatwierdzone przez FDA |
| Mozliwe skutki uboczne |
+3 więcej
|
+4 więcej
|
| Podsumowanie researchu | The source describes a substantial clinical literature for Bivalirudin in PCI and acute coronary syndrome, including randomized comparisons with heparin-based strategies. Reported themes include similar ischemic protection in some comparisons, lower bleeding in several analyses, and discussion of net adverse clinical events when compared with heparin plus glycoprotein IIb/IIIa inhibition. The source also notes research on thrombin inhibition and collagen-dependent platelet activation during PCI. It flags ongoing nuance in the literature, including patient selection and early post-procedure stent thrombosis risk. | The source treats injectable obstetric oxytocin as established, while describing intranasal behavioral research as contested. For social reward, a 2023 systematic review covering 19 randomized, double-blind, placebo-controlled studies and about 984 participants reported a clearer signal in brain-activity outcomes than in behavior or self-report. In autism research, the source cites a 2021 Scientific Reports randomized trial that did not find a substantial empathy-related neural activation change, and it notes that repeated-dose studies have ranged from modest social-behavior findings to no clear effect. Context and sex-specific differences are presented as important reasons the findings remain difficult to generalize. Short-term intranasal trial safety was described as reassuring, but the source does not establish a reliable clinical benefit for these investigational uses. |
| Referencje | ||
| Pełny profil | Zobacz szczegóły | Zobacz szczegóły |
Zapisz to porównanie
Trzymaj ten zestaw researchowy pod reka na darmowym koncie PeptiGuide.
Zapisz porównanie - darmowe kontoTrackuj swoja ścieżkę peptydówa
Zamien research w prywatny log protokołu, gdy będziesz gotowy.
Trackuj ścieżkę peptydówaWyłącznie edukacyjnie. Te informacje są agregowane z publicznych badań i raportów społeczności. To nie jest poradą medyczną, a informacje o dawkowaniu są opisowe, nie rekomendacyjne. Zawsze konsultuj się z wykwalifikowanym specjalistą ochrony zdrowia.